生物活性: |
背景说明:Tyrosinase 369-377, human 是一种来自酪氨酸酶 (tyrosinase) 的 HLA-A2.1 限制性表位多肽,已被应用于开发具有混合疗效的肿瘤靶向疫苗。Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targeted vaccines with mixed efficacy. In Vitro:未检测 参考文献:[1] Chapiro, J. et al. J. Immunol. 176, 1053 (2006); [2] Paczesny, S. et al. JEM 199, 1503 (2004); [3] Lee, P. et al J. Clin. Oncol. 19, 3836 (2001).
|